BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19636062)

  • 1. Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses.
    Seif AE; Barrett DM; Milone M; Brown VI; Grupp SA; Reid GS
    Blood; 2009 Sep; 114(12):2459-66. PubMed ID: 19636062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of novel immunostimulatory CpG ODNs and their anti-leukemic effects as immunoadjuvants of tumor vaccines in murine acute lymphoblastic leukemia.
    Wang J; Zhang W; He A; Zhao W; Cao X
    Oncol Rep; 2011 Feb; 25(2):519-29. PubMed ID: 21165566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model.
    Heckelsmiller K; Rall K; Beck S; Schlamp A; Seiderer J; Jahrsdörfer B; Krug A; Rothenfusser S; Endres S; Hartmann G
    J Immunol; 2002 Oct; 169(7):3892-9. PubMed ID: 12244187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response.
    Reid GS; She K; Terrett L; Food MR; Trudeau JD; Schultz KR
    Blood; 2005 May; 105(9):3641-7. PubMed ID: 15650062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides.
    Fujii H; Trudeau JD; Teachey DT; Fish JD; Grupp SA; Schultz KR; Reid GS
    Blood; 2007 Mar; 109(5):2008-13. PubMed ID: 17068155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
    Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y
    J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute lymphoblastic leukemia cells treated with CpG oligodeoxynucleotides, IL-4 and CD40 ligand facilitate enhanced anti-leukemic CTL responses.
    Fabricius D; Breckerbohm L; Vollmer A; Queudeville M; Eckhoff SM; Fulda S; Strauss G; Debatin KM; Jahrsdörfer B; Meyer LH
    Leukemia; 2011 Jul; 25(7):1111-21. PubMed ID: 21527935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients.
    Blazar BR; Krieg AM; Taylor PA
    Blood; 2001 Aug; 98(4):1217-25. PubMed ID: 11493473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
    Davis HL; Weeratna R; Waldschmidt TJ; Tygrett L; Schorr J; Krieg AM
    J Immunol; 1998 Jan; 160(2):870-6. PubMed ID: 9551923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N; Mukherjee S; Das L; Das PK
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.
    Zimmermann S; Egeter O; Hausmann S; Lipford GB; Röcken M; Wagner H; Heeg K
    J Immunol; 1998 Apr; 160(8):3627-30. PubMed ID: 9558060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells.
    Hofmann C; Dunger N; Grunwald N; Hämmerling GJ; Hoffmann P; Schölmerich J; Falk W; Obermeier F
    Gut; 2010 Oct; 59(10):1347-54. PubMed ID: 20732920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antigen-presenting ability of B lymphoma cells by immunostimulatory CpG-oligonucleotides and anti-CD40 antibody.
    Chen W; Yu Y; Shao C; Zhang M; Wang W; Zhang L; Cao X
    Immunol Lett; 2001 May; 77(1):17-23. PubMed ID: 11348665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells.
    Warren TL; Bhatia SK; Acosta AM; Dahle CE; Ratliff TL; Krieg AM; Weiner GJ
    J Immunol; 2000 Dec; 165(11):6244-51. PubMed ID: 11086059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
    Ballas ZK; Rasmussen WL; Krieg AM
    J Immunol; 1996 Sep; 157(5):1840-5. PubMed ID: 8757300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection.
    Rhee EG; Mendez S; Shah JA; Wu CY; Kirman JR; Turon TN; Davey DF; Davis H; Klinman DM; Coler RN; Sacks DL; Seder RA
    J Exp Med; 2002 Jun; 195(12):1565-73. PubMed ID: 12070284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction.
    Garbi N; Arnold B; Gordon S; Hämmerling GJ; Ganss R
    J Immunol; 2004 May; 172(10):5861-9. PubMed ID: 15128765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG ODN mimicking CpG rich region of myxosporean Myxobolus supamattayai stimulates innate immunity in Asian sea bass (Lates calcarifer) and defense against Streptococcus iniae.
    U-Taynapun K; Chirapongsatonkul N; Itami T; Tantikitti C
    Fish Shellfish Immunol; 2016 Nov; 58():116-124. PubMed ID: 27629917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.